Avatar - Seeking Alpha
Seeking Alpha
Avatar - Seeking Alpha
Avatar - Seeking Alpha

Investing

Moderna up 4% premarket on positive early-stage data supporting potential of mRNA encoding as regenerative therapeutic

Seeking Alpha - Douglas W. House

Moderna (NASDAQ:MRNA) is up 4% premarket on light volume in response to the publication in Nature Communications of results from a Phase 1a/b study …

View on seekingalpha.com
Avatar - Seeking Alpha

Seeking Alpha

Stock market Insights & financial analysis, including free earnings call transcripts, investment ideas and ETF & stock research written by finance experts.